Librax

Chlordiazepoxide, the active ingredient in Librax, is a benzodiazepine presented as a 5 mg/2.5 mg tablet for oral use. It treats gastrointestinal spasm and associated anxiety in adults with functional gastrointestinal disorders.

GNH USA supplies Librax as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Librax combines a benzodiazepine and an anticholinergic to manage functional gastrointestinal disorders and related conditions.

Irritable bowel syndrome: reduces abdominal pain and cramping. Peptic ulcer disease: decreases ulcer‑related pain and gastric hypersecretion. Functional gastrointestinal disorders: alleviates smooth‑muscle spasm and associated anxiety.

Librax may cause a range of adverse reactions, varying from mild to severe.

Common Side Effects: - Drowsiness or fatigue - Dry mouth - Constipation - Dizziness or light‑headedness - Blurred vision

Serious or Rare Side Effects: - Severe respiratory depression, especially with other CNS depressants - Marked hypotension or cardiovascular collapse - Paradoxical agitation or severe confusion - Anaphylactic or severe allergic reactions

Before prescribing Librax, clinicians should consider several safety factors.

Assess anxiety level: evaluate baseline anxiety and dependence risk. Monitor for dependence: benzodiazepine component may lead to tolerance with prolonged use. Avoid in narrow‑angle glaucoma: anticholinergic effect can worsen intra‑ocular pressure. Caution in elderly: increased susceptibility to sedation, falls and confusion. Store at ambient temperature: keep in the original container, protect from moisture and heat.

Librax can interact with several drug classes, requiring careful management.

Major Interactions (Avoid): - Other CNS depressants (e.g., barbiturates, sedative antihistamines): may cause profound sedation. - Alcohol: potentiates sedative and respiratory‑depressant effects. - Opioids: increased risk of respiratory depression and profound CNS depression.

Moderate Interactions (Monitor Closely): - Anticholinergic drugs (e.g., antihistamines, tricyclic antidepressants): additive dry mouth, constipation, urinary retention. - CYP3A4 inhibitors (e.g., ketoconazole, erythromycin): may raise chlordiazepoxide plasma levels. - Antihistamines: enhanced anticholinergic burden leading to confusion in susceptible patients.